Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus

NCT02656082 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Lupus Erythematosus, Discoid
Lupus Erythematosus, Cutaneous
Lupus Erythematosus, Chronic Cutaneous

Interventions

DRUG: Etanercept

Sponsor

University of Leeds

Collaborators

[object Object]
[object Object]
[object Object]